NIH-funded research NIH-funded research

Understanding the molecular changes in various cancers through advanced analysis of tumor samples

Official title: Center for Advanced Multi-Omic Characterization of Cancer

Funded at Battelle Pacific Northwest Laboratories · NIH-11113839 · Data updated 2026-11-12

This study is looking at tumor samples from cancer patients to better understand how cancer works at a molecular level, which could help improve how we diagnose and treat the disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBattelle Pacific Northwest Laboratories
NIH-funded
Lab location1 site (Richland, United States)
Project startJune 1, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$1,240,013
NIH project number5U24CA271012-04
Project IDNIH-11113839 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with high-grade serous ovarian, colon, endometrial cancers, or glioblastoma.

Less likely to help

Patients with cancers not included in the study or those who do not have tumor samples available may not benefit from this research.

What this research studies

This research focuses on characterizing human tumor samples to gain insights into the molecular changes associated with different types of cancer. By integrating multi-omic measurements, including proteomics and metabolomics, the study aims to enhance our understanding of cancer biology and its clinical outcomes. Patients' tumor samples will be analyzed using advanced analytical techniques to explore key biochemical processes and interactions that contribute to cancer progression. The findings could lead to improved diagnostic and therapeutic strategies for cancer treatment.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer diagnostics and personalized treatment options for patients.

How similar studies have gone: Previous research in the field of proteogenomics has shown promising results in enhancing our understanding of cancer biology, indicating that this approach has potential for success.

Where this research is happening

  • Battelle Pacific Northwest Laboratories
    Richland, United States
    Active

Researchers

  • Principal investigator: Liu, Tao — Battelle Pacific Northwest Laboratories
  • Study coordinator: Liu, Tao

Related research

Other NIH-funded projects on the same topics.

  • Proteomics Center for MoTrPAC to map exercise effects in human tissues

    A research center is studying how physical activity changes proteins and their modifications in muscles and fat to understand exercise benefits for chronic diseases.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11516019

  • Islet cell pathways and regulators in early type 1 diabetes

    Researchers will study how insulin-producing beta cells deteriorate before type 1 diabetes becomes clinically apparent, using cutting-edge tissue analysis to find molecular clues that could lead to new therapies.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11457916

  • Protein targets of nitazenes and their metabolites in human cells

    Researchers will map which human brain, heart, and lung proteins interact with nitazene opioids, helping explain why these drugs can be so potent and dangerous.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11440279

  • High-throughput multiomic profiling of single cells

    A new platform will measure proteins, RNAs, and metabolites in thousands of individual human cells to better understand how cells regulate themselves.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11428734

  • Single-cell phospho-proteomics to map breast tumor microenvironment

    A researcher will develop a new, highly sensitive single-cell proteomics tool to map proteins and phosphorylation in breast cancer tumor environments, helping doctors tailor treatments.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11394417

  • High-Throughput Lipid Profiling with Precise Structures for Phenotypic Screening

    A project to develop advanced lipid profiling that can precisely identify lipid structures to help understand and screen diseases like Alzheimer's.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11386439

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.